agilon health, inc. (AGL)
NYSE: AGL · Real-Time Price · USD
1.890
+0.110 (6.18%)
At close: Nov 22, 2024, 4:00 PM
1.880
-0.010 (-0.53%)
After-hours: Nov 22, 2024, 7:55 PM EST
agilon health Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -384.79 | -262.6 | -106.55 | -406.49 | -60.05 | -282.59 |
| Depreciation & Amortization | 22.7 | 16.04 | 8.95 | 10.48 | 13.53 | 12.25 |
| Loss (Gain) From Sale of Assets | 51.33 | 47.55 | - | -0.47 | -20.4 | - |
| Asset Writedown & Restructuring Costs | - | - | - | - | - | 98.34 |
| Loss (Gain) on Equity Investments | -6.33 | -16.49 | -10.72 | 6.94 | -0.51 | 0.75 |
| Stock-Based Compensation | 63.89 | 69.5 | 28.38 | 292.39 | 6.69 | 5.23 |
| Other Operating Activities | -3.03 | -4.25 | 3.75 | -0.18 | 0.5 | -0.18 |
| Change in Accounts Receivable | -460.37 | -460.37 | -204.17 | -149.04 | -59.38 | -23.28 |
| Change in Accounts Payable | 32.11 | 32.11 | 65.74 | 19.36 | 24.92 | 18.45 |
| Change in Other Net Operating Assets | 548.7 | 418.19 | 79 | 74.66 | 40.93 | 38.01 |
| Operating Cash Flow | -135.36 | -156.2 | -130.81 | -148.16 | -53.2 | -103.86 |
| Capital Expenditures | -13.92 | -15.83 | -15.43 | -6.56 | -1.78 | -2.89 |
| Cash Acquisitions | -0.77 | -45.25 | - | - | - | - |
| Divestitures | 2.19 | 2.19 | 0.5 | -1.34 | 26.21 | - |
| Sale (Purchase) of Intangibles | -30.33 | -14.99 | -17.24 | -6.86 | -0.58 | -1.01 |
| Investment in Securities | 177.33 | 49.38 | -405.72 | 7.1 | 2.06 | - |
| Investing Cash Flow | 114.02 | -44.02 | -444.39 | -90.51 | 22.07 | -5.06 |
| Long-Term Debt Issued | - | - | - | 100 | - | - |
| Long-Term Debt Repaid | - | -5 | -5 | -119.9 | -3.04 | -3.59 |
| Net Debt Issued (Repaid) | -5 | -5 | -5 | -19.9 | -3.04 | -3.59 |
| Issuance of Common Stock | 1.59 | 11.87 | 33.06 | 1,189 | 34.4 | 180.19 |
| Repurchase of Common Stock | - | -200 | - | - | -6.74 | - |
| Other Financing Activities | - | - | - | -14.74 | - | -0.3 |
| Financing Cash Flow | -3.41 | -193.13 | 28.06 | 1,154 | 24.62 | 176.3 |
| Net Cash Flow | -24.75 | -393.35 | -547.14 | 915.73 | -6.52 | 67.38 |
| Free Cash Flow | -149.28 | -172.03 | -146.23 | -154.72 | -54.98 | -106.75 |
| Free Cash Flow Margin | -2.67% | -3.99% | -6.12% | -10.17% | -4.51% | -13.44% |
| Free Cash Flow Per Share | -0.37 | -0.42 | -0.36 | -0.41 | -0.17 | -0.36 |
| Cash Interest Paid | 4.54 | 5.8 | 3.67 | 4.82 | 7.09 | 8.04 |
| Cash Income Tax Paid | 0.75 | 5.36 | 5.31 | 1.82 | 0 | 0.03 |
| Levered Free Cash Flow | -90.05 | -70.94 | -131.98 | 4.09 | -21.15 | - |
| Unlevered Free Cash Flow | -85.93 | -66.77 | -129.18 | 7.94 | -16.06 | - |
| Change in Net Working Capital | -86.43 | -23.76 | 68.93 | 51.52 | -1.71 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.